It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.
from US Top News and Analysis https://ift.tt/DR2FftV
from US Top News and Analysis https://ift.tt/DR2FftV
Comments
Post a Comment